Archean Chemical Industries Q1 FY27 earnings call

Archean Chemical Industries Limited reported a robust Q1 FY27, with standalone revenue reaching INR 3,321 million, marking a 14% year-on-year and 9% sequential growth, the highest in five quarters. Standalone EBITDA stood at INR 838.7 million, a 26.3% sequential increase, with margins expanding from 21.8% in Q4 FY26 to 25.3%. The bromine segment was a key driver, delivering INR 1,333 million in revenue (up 58% YoY) on 4,175 tons of volume, with realizations up 50% YoY. Notably, the derivatives business, Acume, turned EBITDA positive for the first time, reporting INR 19 million against a loss of INR 27 million in Q1 last year.

Despite strong performance in bromine, overall profitability was impacted by higher logistics costs and raw material price variances. Industrial salt volumes declined by 12% YoY to 982,000 tons, generating INR 1,713 million in revenue. This was primarily due to vessel shortages, fuel supply issues, and order deferments from QVC due to the Middle East conflict. Logistics costs increased by approximately INR 40 crores YoY, with 60% attributed to increased road distances and 40% to a 40-50% rise in diesel prices. Management expects salt volumes to normalize from Q3 FY27, with double-digit growth, as road construction completes by September and fuel prices ease.

The company made significant progress on its strategic projects. Phase 1 trials for Sulphate of Potash (SOP) were successfully completed, and Phase 2 trials are on track for completion by Q3 FY27, aiming to validate the modified process for commercial production. SOP revenue for the quarter was INR 113 million on sales of 1,952 tons. The SiCSem semiconductor product project in Odisha is moving into execution as per schedule, with construction expected to commence in late August/early September. The total project capex is USD 249 million, with 15-20% already incurred, and 60-65% of the balance planned for the current fiscal year.

The oilfield chemicals business (Idealis) reported muted revenue of INR 3.5 million and an EBITDA loss of INR 13.4 million, as it remains in an early stage focused on plant readiness and trial orders. Demand is largely driven by exploration in overseas markets, with Indian offshore drilling not seeing huge expansions. The company is developing new products for this segment, including pack and starch (expected meaningful volumes in H2 FY27) and bentonite/barite (volumes by end of FY27), with some products currently in customer trials. Management emphasized that it is a long-cycle adoption industry requiring sustained development.

To mitigate operational challenges and enhance recovery, Archean is optimizing routes, contracting additional fleets, and revising dispatch schedules. Brine field expansions, crucial for feedstock, are on schedule, with most of Phase 1 completed and commissioning anticipated post-monsoons. These efforts, alongside ongoing discussions for land lease extension with the Gujarat government, aim to secure long-term operational stability and improve feedstock access, addressing past challenges related to structural shifts in brine characteristics.